Tien M. Truong
University of South Florida(US)
Publications by Year
Research Areas
Protease and Inhibitor Mechanisms, Pharmacogenetics and Drug Metabolism, Cell Adhesion Molecules Research, Peptidase Inhibition and Analysis, Obstructive Sleep Apnea Research
Most-Cited Works
- → Potent and Specific Inhibition of Human Leukocyte Elastase, Cathepsin G and Proteinase 3 by Sulfone Derivatives Employing the 1,2,5-Thiadiazolidin-3-one 1,1 Dioxide Scaffold(1998)71 cited
- → Utilization of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold in the design of potent inhibitors of serine proteases: SAR studies using carboxylates(2000)51 cited
- → Design, synthesis, and in vitro inhibitory activity toward human leukocyte elastase, cathepsin G, and proteinase 3 of saccharin-derived sulfones and congeners(1996)39 cited
- → Potent inhibition of serine proteases by heterocyclic sulfide derivatives of 1,2,5-thiadiazolidin-3-one 1,1 dioxide(2000)34 cited
- → Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients(2021)28 cited
- → US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer(2024)23 cited
- → Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial(2020)21 cited
- → 1,2,5-Thiadiazolidin-3-one 1,1 Dioxide: A Powerful Scaffold for Probing the S′ Subsites of (Chymo)trypsin-Like Serine Proteases(2001)21 cited
- → The ImPreSS Trial: Implementation of Point‐of‐Care Pharmacogenomic Decision Support in Perioperative Care(2019)17 cited
- → Patient insights on features of an effective pharmacogenomics patient portal(2020)15 cited